The pharmacological effects of inhaled cannabis on pain in patients with multiple sclerosis: risks versus rewards Zaid H. MaayahJason R. B. Dyck Commentary 29 August 2020 Pages: 1073 - 1076
Coronavirus (Covid-19) sepsis: revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality Santosh Shenoy Review 07 August 2020 Pages: 1077 - 1085
Metabolic reprogramming as a key regulator in the pathogenesis of rheumatoid arthritis Wei-wei CaiYun YuFang Wei Review 14 August 2020 Pages: 1087 - 1101
Mast cells and angiogenesis in multiple sclerosis Domenico RibattiRoberto TammaTiziana Annese Review 17 August 2020 Pages: 1103 - 1110
IL-33 deficiency protects mice from DSS-induced experimental colitis by suppressing ILC2 and Th17 cell responses Xueying QiuChang QiMin Fang Original Research Paper 29 July 2020 Pages: 1111 - 1122
Anti-inflammatory capacity of Apremilast in human chondrocytes is dependent on SOX-9 Yanjie ZhangXiaohan HuangYanhao Yuan Original Research Paper 18 August 2020 Pages: 1123 - 1132
Sleep deprivation aggravated lipopolysaccharide/d-galactosamine-induced acute liver injury by suppressing melatonin production Lu LiuLi ZhangLing Tang Original Research Paper 18 August 2020 Pages: 1133 - 1142
Biochanin A impedes STAT3 activation by upregulating p38δ MAPK phosphorylation in IL-6-stimulated macrophages Anandita BasuAnindhya Sundar DasRupak Mukhopadhyay Original Research Paper 27 August 2020 Pages: 1143 - 1156
Correction to: Optimized THP-1 differentiation is required for the detection of responses to weak stimuli E. K. ParkH. S. JungK. S. Kim Correction 12 September 2020 Pages: 1157 - 1157